lemurinus griseimembra indicates that this trial, although using only small numbers of animals, has shown a highly significant protective effect which is convincingly explained by very specific antibody responses to defined epitopes within MSP-1 Block 2.
← all excerpts
Antibody responses to a novel Plasmodium falciparum merozoite surface protein vaccine correlate with protection against experimental malaria infection in Aotus monkeys.
1
—
—